Syncona (SYNC) is a large British closed-ended investment fund targeting healthcare and life science investments. The company focuses on equity, hedge, and long-term alternative investment funds across various asset classes in the markets worldwide. It manages fixed income, debt, private equity, and alternative investments. It operates in two segments: life science portfolio and fund investments. The company makes its life science investments through Syncona Holdings Limited and its fund investments through Syncona Investments LP Incorporated. The Syncona share price is listed on the London Stock Exchange and included in the FTSE 250 Index.
You can find the latest SYNC share price at Capital.com.
Latest shares articles
Trading Nasdaq 100’s fresh record high
Progress on the trade front, easing geopolitical tensions, and ‘revenge tax’ removed sees risk appetite improve.
11:02, 30 June 2025
Capital.com expands industry engagement as it joins Innovate Finance and the London Chamber of Commerce and Industry
Memberships signify commitment to actively participate in the development and transformation of the UK’s financial and technology sectors.
09:11, 30 June 2025
Capital.com enhances EU Client protection with up to 1 million euro insurance cover
Capital.com announced the launch of a new enhanced insurance scheme specifically for clients across the European Union (EU).
09:13, 26 June 2025
Buffett’s cash pile just got even larger
Warren Buffett just announced he's stepping down as CEO of Berkshire Hathaway – and he's leaving his successor a massive pile of cash. Since 2024, Buffett has sold off a massive amount of stock, more than doubling Berkshire's cash position from $167bn to $348bn.
18:05, 25 June 2025
Ratings and Reviews
Ratings and Reviews
